Prelude Therapeutics Inc (PRLD) Directors and Executive Officers - CSIMarket
CSIMarket
 
Prelude Therapeutics Inc  (NASDAQ: PRLD)

Prelude Therapeutics Inc

Officers & Directors


Krishna Vaddi, Ph.D.
Chief Executive Officer and Director - (Principal Executive Officer)

Mardi C. Dier
Director -

David Bonita
Director -

Julian Baker
Director -

Paul A. Friedman
Chairman and Director -

Martin Babler
Director -

Laurent Chardonnet
Chief Financial Officer - (Principal Accounting and Financial Officer)

Victor Sandor
Director - ,

Prelude Therapeutics Inc currently has 79 employees.






PRLD Management Effectiveness PRLD Revenue per Employee PRLD Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.